Journal of Postgraduate Medicine
 Open access journal indexed with Index Medicus & ISI's SCI  
Users online: 8691  
Home | Subscribe | Feedback | Login 
About Latest Articles Back-Issues Articlesmenu-bullet Search Instructions Online Submission Subscribe Etcetera Contact
 
Read this article

 


    Article Cited by others

ADR REPORT

Montelukast induced acute hepatocellular liver injury

Harugeri A, Parthasarathi G, Sharma J, D«SQ»Souza G A, Ramesh M

Year : 2009| Volume: 55| Issue : 2 | Page no: 141-142

   This article has been cited by
 
1 Leukotrienes vs. Montelukast—Activity, Metabolism, and Toxicity Hints for Repurposing
Cátia F. Marques, Maria Matilde Marques, Gonçalo C. Justino
Pharmaceuticals. 2022; 15(9): 1039
[Pubmed]  [Google Scholar] [DOI]
2 Worldwide Use of RUCAM for Causality Assessment in 81,856 Idiosyncratic DILI and 14,029 HILI Cases Published 1993–Mid 2020: A Comprehensive Analysis
Rolf Teschke, Gaby Danan
Medicines. 2020; 7(10): 62
[Pubmed]  [Google Scholar] [DOI]
3 RUCAM in Drug and Herb Induced Liver Injury: The Update
Gaby Danan,Rolf Teschke
International Journal of Molecular Sciences. 2015; 17(1): 14
[Pubmed]  [Google Scholar] [DOI]
4 Montelukast-loaded nanostructured lipid carriers: Part I Oral bioavailability improvement
Arpana Patil-Gadhe,Varsha Pokharkar
European Journal of Pharmaceutics and Biopharmaceutics. 2014;
[Pubmed]  [Google Scholar] [DOI]
5 Montelukast-Induced Adverse Drug Reactions: A Review of Case Reports in the Literature
Gioacchino Calapai, Marco Casciaro, Marco Miroddi, Fabrizio Calapai, Michele Navarra, Sebastiano Gangemi
Pharmacology. 2014; 94(1-2): 60
[Pubmed]  [Google Scholar] [DOI]
6 Current awareness: Pharmacoepidemiology and drug safety
Pharmacoepidemiology and Drug Safety. 2010; 19(2): i
[HTML Full text]  [Google Scholar] [DOI]

 

Online since 12th February '04
© 2004 - Journal of Postgraduate Medicine
Official Publication of the Staff Society of the Seth GS Medical College and KEM Hospital, Mumbai, India
Published by Wolters Kluwer - Medknow